Echo IQ (ASX:EIQ) said it concluded its presentation to the American Medical Association's CPT editorial panel meeting regarding its application for a category III current procedural technology (CPT) code for its EchoSolv aortic stenosis (AS) artificial intelligence imaging technology in the US, according to a Friday Australian bourse filing.
It added that it had not received an indication of the panel votes at the time of the filing, despite media speculation. Results will be posted by the association in the coming two to four weeks.
The firm's shares fell 18% in recent trading on Friday.